CD44 and central nervous system cancer: HIF‐2α (Hypoxia-Inducible Factor 2α) expression is also regulated by CD44‐OPN interaction through a CBP/p300‐dependent mechanism (mediated by CD44-ICD) and it has been demonstrated to promote stem-like properties and tumoral aggressiveness in glioma cells (51).